Why CEOs in Pharma Need a Crash Course in R&D Speak

Ever wondered why pharmaceutical CEOs might need extra education? Well, it's not just about business and finance anymore. These top bosses often struggle with understanding the complex world of research and development (R&D). Unlike their staff, who spend years learning the ropes, CEOs may not grasp the ins and outs of discovering new medicines, ensuring safety, or managing risks. This gap can make it tough for them to make informed decisions. So, what's the solution? We say CEOs should dive into some serious R&D learning.

This isn't just about understanding the lingo, but also about getting a feel for the timelines and issues involved. After all, better decisions mean better medicines and happier patients. Programs like PharmaTrain 3. 0 can help with this. They offer a structured way to learn the skills needed to navigate the R&D maze. By bridging this knowledge gap, CEOs can make more reasoned choices that benefit both business and patients.

Actions